Oncogastroenterology

J Clin Oncol. 2016 Apr 1;34(10):1154-5. doi: 10.1200/JCO.2015.65.7973. Epub 2016 Feb 1.

Authors

Shilpa Grover¹, Ramona M Lim², Richard S Blumberg³, Sapna Syngal²

Affiliations

¹ Brigham and Women's Hospital and Harvard Medical School, Boston, MA sgrover@bwh.harvard.edu.
² Brigham and Women's Hospital and Harvard Medical School and Dana-Farber Cancer Institute, Boston, MA.
³ Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

PMID: 26834060
DOI: 10.1200/JCO.2015.65.7973

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects
Chemotherapy, Adjuvant / adverse effects
Chronic Disease
Gastroenterology* / methods
Gastroenterology* / trends
Gastrointestinal Tract / drug effects*
Gastrointestinal Tract / radiation effects*
Humans
Medical Oncology* / methods
Medical Oncology* / trends
Neoplasms / drug therapy
Neoplasms / radiotherapy
Neoplasms / therapy*
Quality of Life
Radiotherapy, Adjuvant / adverse effects
Survivors

Substances

Antineoplastic Agents

Grants and funding